#cannabisaficionado

Culture

‘Masterclass in Medical Cannabis’ Signals Global Change in Cannabis Opinion

Published

on

Masterclass in Medical Cannabis
PHOTO | cendeced

The global trend in cannabis legalization and acceptance of the plant as medicine took another leap forward recently. New Zealand’s largest medical cannabis firm and the leading British expert in medical cannabis recently joined forces to host a ‘Masterclass in Medical Cannabis’ series to educate local doctors and healthcare professionals about the benefits of incorporating the plant into their prescription.

Professor Mike Barnes, a highly experienced consultant neurologist and the Director of Education for the Academy of Medical Cannabis based in London, and Helius Therapeutics hosted three ‘Masterclass in Medical Cannabis’ events in Auckland, Wellington and Christchurch, the first RNZCGP-endorsed professional training of its kind.

Paul Manning, CEO of Helius believes it is “absolutely critical that New Zealand’s doctors have access to professional training in advance of locally-produced medicinal cannabis products becoming widely available from next year.”

“As the country’s largest medical cannabis firm, I feel it’s incumbent on Helius to invest in educational opportunities for healthcare professionals, in what is a rapidly emerging field of clinical practice,” said Manning.

We sat down with Prof. Barnes and Paul Manning to discuss the importance of education, the global trend of cannabis legalization and their mutual concern of the specialist sign-off requirement that’s recommended in the discussion document on New Zealand’s Medicinal Cannabis Scheme.

Professor Mike Barnes

Professor Mike Barnes

Cannabis Aficionado: Why do you think doctors are so hesitant to prescribe medical cannabis?

Professor Mike Barnes: There are several reasons: lack of knowledge and lack of guidance, also medical cannabis products being unapproved medicines, which means the doctor had to take additional responsibility — so they can be scared of prescribing!

Education is key to informed decision making. In an ideal world, what educational resources would you like medical professionals to have access to?

As many different formats as possible. On-line training, one-day masterclasses like we ran in New Zealand, and written material.

What do you think the most compassionate legal cannabis model looks like?

Wide access to all that may benefit without restriction on conditions that can be treated. Leave it up to the doctor to decide whether its right for that patient (like any other medicine). Allow all doctors (specialists and GPs) to prescribe any GMP standard product.

What parallels do you believe New Zealand has with the U.K. with regards to thoughts around cannabis legalization?

Very similar — general doctor reluctance to be involved — although I felt much more interest than we have in the U.K. That’s for medical cannabis of course. General legalization for recreational use is at about 50:50 split in the U.K. now — similar again to New Zealand.

Have you seen N.Z.’s proposed medical cannabis scheme? If yes, what are your thoughts?

Yes, and it’s generally excellent. The main issue is the proposed prescribing restriction that requires specialist sign off, which is unnecessary. I believe that GPs would make very good prescribers as medical cannabis is mainly a symptom treater and GPs treat the sort of symptoms that cannabis helps all the time, such as chronic pain, anxiety, sleep problems, etc.

What three things do you wish all doctors knew about medical cannabis?

That it is very safe. It is generally different from unregulated cannabis and there is good evidence for several indications.

Any advice for New Zealand moving forward with legalization?

Make medical cannabis products available through GPs without the need for a specialist recommendation. Help all doctors to learn by organizing a range of educational opportunities. And don’t rely on the traditional medical bodies to provide guidance, as they are usually far too conservative – the wrong generation!

Paul Manning, CEO, Helius Therapeutics

Paul Manning, CEO, Helius Therapeutics

Cannabis Aficionado: Why does Helius believe that educating doctors is so important?

Paul Manning: Thousands of suffering New Zealanders will be relying on their GPs for professional advice about medicinal cannabis for a range of therapeutic possibilities, and if appropriate, to access to products on prescription. We strongly believe every Kiwi has a natural right to a pain-free existence.

However, access will not improve unless doctors are well-informed about medical cannabis and how to prescribe the products. Let’s not repeat the mistakes of Australia and the U.K., where doctors were simply unprepared for the changes, causing widespread frustration among patients.

This initiative marked New Zealand’s first RNZCGP-endorsed professional training in medicinal cannabis for doctors on a national scale. It’s a major milestone for our burgeoning medicinal cannabis industry, as well as the healthcare sector.

How did Prof. Barnes become involved?

Mike became widely known after the U.K. Government commissioned him in 2016 to assess evidence for the medical use of cannabis. I had read this report, Cannabis: The Evidence for Medical Use. It helped to change the direction of legislation in the U.K. and acted as a catalyst to the eventual rescheduling of medicinal cannabis in November 2018. He is also the author of more than a dozen books and 200 published papers, several of which have been referenced by our team.

Mike also famously consulted to Alfie Dingley’s case in England, a six-year-old boy who suffers from a rare form epilepsy that was causing up to 150 seizures a month. His seizures have been since dramatically reduced after being given cannabis products. Mike is the Director of Education at The Academy of Medical Cannabis, so I reached out to him about this opportunity.

Did he enjoy himself?

Absolutely. We had an ambitious schedule, to deliver three full-day masterclasses in three cities, so we were flat out, but it was a lot of fun too! I think Mike really liked New Zealand and I know he was very encouraged by the positive response from healthcare professionals down here.

What has the feedback been from attendees?

We had 330 healthcare professionals attend the three masterclasses. The feedback has been fantastic. The majority of attendees were general practitioners. It was a big commitment to join the class for a whole day, and I think this demonstrates just how open-minded many doctors are to medical cannabis.

What is the biggest reason you believe cannabis should be legalized for medical purposes?

Cannabis is an extraordinary, natural treatment for many chronic conditions. These products present alternative to many harsh drugs, such opioids, and can improve the lives of millions of people across the world.

What is one thing you wish people knew about the therapeutic benefits of medical cannabis?

You don’t need to get high to get healthy. Even products that contain THC need not necessarily come with a euphoric effect.

How can the public educate themselves on medical cannabis?

There are some wonderful resources available online, such as Project CBD. There’s a fantastic book by the National Academies of Sciences, Engineering, and Medicine with the snappy title The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. We’re also working on a unified repository of the world’s published cannabis research, which will be launched in 2020.

Any plans for more events like this again?

You bet. The Masterclasses in Medical Cannabis were just the start. We’ll be rolling out a program of professional and public education initiatives over the next 24 months. Helius has also just signed a quarter-million dollar commitment with BiotechNZ to stage a major education event in New Zealand early next year.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Culture

Network in Paradise at the CanEx Jamaica Business Conference & Expo

Published

on

CanEx Jamaica
PHOTO | Konstiantyn

According to a new report by Grand View Research, Inc, the global legal cannabis market is expected to reach USD 66.3 billion by the end of 2025. Helped in part by the increasing acceptance of cannabis to treat numerous medical conditions such as Parkinson’s disease, cancer, arthritis, and neurological disorders, along with the lucrative revenue created by legal cannabis sales, there has never been a more crucial time for entrepreneurs and businesses to network and expand their businesses on a global scale.

As one of the leaders in international business-to-business (B2B) events, the CanEx Jamaica Business Conference and Expo brings together top cannabis industry experts from around the globe including the U.S., Canada, Europe, Australia and the Caribbean.

Taking place September 26-28 at the Montego Bay Convention Center, in beautiful Montego Bay, the fourth annual CanEx Jamaica Business Conference & Expo features addresses, panel discussions and presentations on a variety of topics — from advocacy, cultivation, science and medicine to investment, banking and finance, and the business of cannabis including women entrepreneurship.

Over 70 world-class speakers and panelists will provide insights into the direction of the global cannabis industry to over 3,000 delegates.

Steve DeAngelo, founder of Harboride dispensary and the Last Prisoner Project, is speaking on two panels — “Post Decriminalization of Cannabis: Towards Restorative Justice” and “Strategic Approaches to Cannabis Investments” to how the investment landscape is evolving.

Bruce Linton, founder of Canopy Growth Corp, the first cannabis producing company in North America to be listed on a major stock exchange, will host a fireside chat with CanEx founder, Douglas K. Gordon.

Former President of Mexico, Vicente Fox, will host “The Global Cannabis Movement” that will explore what globalization means in practical terms for the industry, where things stand presently and the future of the global market.

Cam Battley, Chief Corporate Officer of Aurora Cannabis Inc., will be speaking on the panel “CEO Roundtable: Roadmap to Sustainable Profitability for the Industry” to discuss the global challenges and opportunities facing the cannabis Industry.

Plus, over 200 exhibitors and sponsors, from cultivators to investment firms and media experts will provide attendees opportunities for networking, business expansion and identify new areas of growth within the legal industry.

Held for the first time in 2016, CanEx Jamaica is responsible for connecting cannabis experts, researchers, business professionals, creating new strategic partnerships in a truly memorable and vibrant setting.

For more information, visit canexjamaica.com.

Continue Reading

Culture

After 25 Years, Supreme Closes Iconic Lafayette Store

Published

on

PHOTO | Supreme

In a move that has shocked through the streetwear community, Supreme has closed its original space on Lafayette after 25 years of business.

Back in February, the brand announced that its famous Lafayette location would be under renovation. Now, due to the unforeseen closure, the 190 Bowery location in Manhattan will now be the brand’s main location in the Big Apple.

 

View this post on Instagram

 

Celebrating 25 years. Pooky, Lafayette Street, New York City 1995 📷 @suekwon_

A post shared by Supreme (@supremenewyork) on

Continue Reading

Culture

Off the Record, It’s National Expungement Week

Published

on

National Expungement Week

“Would you like to know an absolutely crazy fact? There are 77 million people in the United States who have a criminal record.” This crazy statistic that instantly grabs your attention is how Seth Rogen opens the PSA for National Expungement Week.

Rogen also asks, “What does ‘expungement’ mean?” ‘On the record’, expungement means, clearing or sealing the record of a person’s prior arrest, criminal charges or conviction.

That’s a possibility for some of the 77 million people with criminal records — a large amount being minor offenses — which make up nearly a quarter of the population of the United States. Having a criminal record seriously impedes the ability to live for millions of people. It restricts access to jobs, housing, education, and the right to vote.

National Expungement Week aka N.E.W. is the initiative of Cage-Free Repair (the non-profit section of Cage-Free Cannabis) Cannabis and Equity First Alliance.

Cage-Free Cannabis is rooted in three kinds of justice, from reparative, to economic and environmental. Equity First Alliance works to bring reparative justice to, and be a voice for, those who have been most harmed by the War on Drugs.

The initiative will see over 40 events held in 30 cities, which will host workshops, allowing people to meet with lawyers and experts who can help them clear records, from September 21-28.

Among other company’s and businesses, N.E.W. is supported by Houseplant, the cannabis company launched by Rogen and Evan Goldberg, in the hopes of exposing the social injustices associated with cannabis convictions.

With 18 events in 15 cities that helped nearly 300 people begin the process of changing their records, the inaugural National Expungement Week in 2018 was clearly a success and led to the initiative returning this year.

If you’re interested in clearing your record or helping someone else do the same, you can find further information — including the dates and details of specific events — on the official site of N.E.W.; offtherecord.us.

Continue Reading

Trending

Join The Cannabis Aficionado Community!

Copyright © Cannabis Aficionado